Confirmed title: Effective supplier relationship development through the Supplier Relationship Mapping

19 June: 10:00 - 10:30

Alessandro Fazio, Non Clinical Outsourcing Manager, CHIESI FARMACEUTICI SPA

ABSTRACT

Effective Supplier Relationship development though the Supplier Relationship Mapping.

Supplier Relationship Mapping is a process involving a number of different tools and techniques, that can provide Pharma R&D with competitive advantages through the analysis, management and leverage of their relationships with R&D service providers. Both Pharma R&D and Outsourcing departments should develop a structured understanding of the status quo, deeply investigating the nature of current relationships that exist within and between Pharma R&D organizations and their service providers.

Supplier Relationship Mapping relies on five core concepts: (i) Balance of power; (ii) Supplier preferencing; (iii) Supplier constituency mapping; (iv) Reverse marketing; (v) Relationship management. Supplier Relationship Mapping should be run together with Portfolio Analysis, a tool to help Pharma R&D identifying appropriate strategic options and tactical actions based on two of the most critical aspects of R&D services’ market: (a) Market difficulty/risk, and (b) Relative value/profit impact.

The combination of understanding Pharma R&D position from service providers’ viewpoint and understanding service providers’ position vis à vis the marketplace, enhances Pharma R&D strategic decision-making process, thus leading to a well-chosen outsourcing approach

BIOGRAPHY

Alessandro Fazio works as R&D Outsourcing Manager (Non-Clinical) at Chiesi Farmaceutici Spa since 2017 (Parma, Italy). He is mainly responsible for managing the outsourcing activities within the Preclinical area (drug discovery, medicinal chemistry, toxicology, pharmacology and DMPK) and the CMC area for biologics (protein, enzyme and cell culture).

Alessandro holds a PhD in Systems Biology from the Technical University of Denmark and he worked as Optimization Scientist for enzyme production at Novozymes A/S and as Innovation Project Manager for Commercial Development at Chr Hansen A/S (both positions in Copenhagen, Denmark).

COMPANY PROFILE

The Chiesi Group is an international company based in Parma, with more than 80 years of experience and a strong focus on research, development, production and the commercialisation of innovative medicines in the Respiratory, Neonatology, Rare Disease and Special Care Therapeutic Areas.

The Chiesi Group exports to more than 80 countries with a direct presence in 28, with a turnover of more than €1,768 millions sales.

Its R&D centres in Parma (Italy), Paris (France), Cary (USA), Chippenham and Oxford (UK) and Lidingo (Sweden), integrate their efforts to advance Chiesi's pre-clinical, clinical and registration programmes.

The Chiesi Group employs approximately 5,624 people, 788 of whom are dedicated to R&D activities and 809 of whom work at the production sites in Parma (Italy), Blois (France) and Santana De Parnaiba (Brazil).